Jessica Fung analyst JPMORGAN

Currently out of the existing stock ratings of Jessica Fung, 1 are a SELL (4.76%), 10 are a HOLD (47.62%), 10 are a BUY (47.62%).

Jessica Fung

Work Performance Price Targets & Ratings Chart

Analyst Jessica Fung, currently employed at JPMORGAN, carries an average stock price target met ratio of 100% that have a potential upside of 24.86% achieved within 541 days. Previously, Jessica Fung worked at GOLDMAN SACHS.

Jessica Fung’s has documented 40 price targets and ratings displayed on 4 stocks. The coverage is on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 13-Oct-2025.

Wall Street Analyst Jessica Fung

Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 8/26/2024. The price target of $280 was fulfilled within 1 day with a profit of $10.86 (4.04%) receiving and performance score of 40.35.

Average potential price target upside

PAAS Pan American Silver Corp. UTHR United Therapeutics ALNY Alnylam Pharmaceuticals HL Hecla Mining Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Aug-2023

$69

$19.01 (38.03%)

$51

2 months 15 days ago
(09-Jul-2026)

5/6 (83.33%)

$24.88 (56.39%)

92

Buy Since 03-Apr-2023

$64

$18.55 (40.81%)

7 months 29 days ago
(26-Jan-2026)

12/12 (100%)

$-0.65 (-1.01%)

101

$55

$5.01 (10.02%)

$42

9 months 14 days ago
(10-Dec-2025)

5/5 (100%)

$6.47 (13.33%)

428

Buy Since 22-May-2024

$62

$16.55 (36.41%)

$46

11 months 14 days ago
(10-Oct-2025)

7/7 (100%)

$23.75 (62.09%)

325

Hold Since 12-Jul-2024

$23

1 years 5 months 9 days ago
(15-Apr-2025)

2/2 (100%)

$1.99 (9.47%)

11

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Jessica Fung?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?